^
Association details:
Evidence:
Evidence Level:
Sensitive: C3 – Early Trials
Source:
Title:

Preliminary efficacy from an ongoing phase 1 dose escalation study of seclidemstat (SP-2577) in patients (pts) with advanced solid tumors (AST).

Published date:
05/19/2021
Excerpt:
SALA-003-AC19 (NCT03895684) is a phase 1 trial of single agent SP-2577 in pts with AST...19 pts with AST (10 sarcoma, 2 prostate, 2 ovarian, 2 pancreatic, 1 renal, 1 cervical, 1 breast) were enrolled….Extra-skeletal myxoid chondrosarcoma...TAF15-CHN…Best overall response...SD...
DOI:
10.1200/JCO.2021.39.15_suppl.3073
Trial ID: